nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

27.04.2022 | Original Article – Cancer Research

miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification

verfasst von: Bin Han, Ke Xu, Dan Feng, Yang Bai, Yangqi Liu, Yuanyuan Zhang, Liming Zhou

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Colorectal cancer (CRC) is a severe health condition characterized by high mortalities. NudC domain containing 1 (NUDCD1) is abnormally upregulated in multiple tumors and is recognized as a cancer antigen. In CRC, NUDCD1 upregulation accelerates tumor progression by activating the IGF1R-ERK1/2 signaling pathway. Its specific regulatory mechanisms, however, remain unclear.

Methods

In the present study, we predicted the regulators of NUDCD1 and analyzed the expression profile of NUDCD1 in CRC tissues using the gene chip dataset. We also determined the regulation between miR-144, NUDCD1 and IGF1R-ERK1/2 signaling in vitro and in vivo. Then, the expression of miR-144 in CRC tissues was detected and its cell functions were verified in vitro.

Results

As predicted by bioinformatics, we found that NUDCD1 is a predicted target of miR-144 and confirmed that miR-144 directly binds to NUDCD1. In vitro and in vivo, miR-144 was determined to specifically regulate NUDCD1 expression and as such, can reduce the activity of the IGF1R-ERK1/2 signaling pathway. Moreover, miR-144 was significantly downregulated in CRC tissues; its levels were significantly negatively correlated with CRC primary range and lymph node metastasis. Cell function studies verified that miR-144 acts as a tumor suppressor, because it significantly inhibits the proliferation, metastasis, and invasion of CRC cells as well as inducing cell cycle arrest and apoptosis.

Conclusions

Our study demonstrates that miR-144 regulates IGF1R-ERK1/2 signaling via NUDCD1 to inhibit CRC cell proliferation and metastasis. The miR-144/NUDCD1/IGF1R-ERK1/2 signaling axis may be crucial in the progression of CRC.

Nur mit Berechtigung zugänglich

Asselin-Mullen P, Chauvin A, Dubois ML, Drissi R, Levesque D, Boisvert FM (2017) Protein interaction network of alternatively spliced NudCD1 isoforms. Sci Rep 7:12987. https://doi.org/10.1038/s41598-017-13441-wCrossRefPubMedPubMedCentral

Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233. https://doi.org/10.1016/j.cell.2009.01.002CrossRefPubMedPubMedCentral

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492CrossRefPubMed

Brenner H, Kloor M, Pox CP (2014) Colorectal Cancer. Lancet 383:1490–1502. https://doi.org/10.1016/S0140-6736(13)61649-9CrossRefPubMed

Brodersen P, Voinnet O (2009) Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 10:141–148. https://doi.org/10.1038/nrm2619CrossRefPubMed

Cao ZQ, Wang Z, Leng P (2019) Aberrant N-cadherin expression in cancer. Biomed Pharmacother 118:109320. https://doi.org/10.1016/j.biopha.2019.109320CrossRefPubMed

Cao HL, Gu MQ, Sun Z, Chen ZJ (2020) miR-144-3p contributes to the development of thyroid tumors through the PTEN/PI3K/AKT pathway. Cancer Manag Res 12:9845–9855. https://doi.org/10.2147/CMAR.S265196CrossRefPubMedPubMedCentral

Chen W et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132. https://doi.org/10.3322/caac.21338CrossRefPubMed

Chen G et al (2018) Lico A causes er stress and apoptosis via up-regulating miR-144-3p in human lung cancer cell line H292. Front Pharmacol 9:837. https://doi.org/10.3389/fphar.2018.00837CrossRefPubMedPubMedCentral

Cheng B, Zhang Y, Wu ZW, Cui ZC, Li WL (2020) MiR-144 inhibits colorectal cancer cell migration and invasion by regulating PBX3. Eur Rev Med Pharmacol Sci 24:9361–9369. https://doi.org/10.26355/eurrev_202009_23019CrossRefPubMed

Davis MI et al (2016) Small molecule inhibition of the ubiquitin-specific protease USP2 accelerates cyclin D1 degradation and leads to cell cycle arrest in colorectal cancer and mantle cell lymphoma models. J Biol Chem 291:24628–24640. https://doi.org/10.1074/jbc.M116.738567CrossRefPubMedPubMedCentral

Dino P, D’Anna C, Sangiorgi C, Di Sano C, Di Vincenzo S, Ferraro M, Pace E (2019) Cigarette smoke extract modulates E-cadherin, claudin-1 and miR-21 and promotes cancer invasiveness in human colorectal adenocarcinoma cells. Toxicol Lett 317:102–109. https://doi.org/10.1016/j.toxlet.2019.09.020CrossRefPubMed

Dweep H, Sticht C, Pandey P, Gretz N (2011) miRWalk–database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. J Biomed Inform 44:839–847. https://doi.org/10.1016/j.jbi.2011.05.002CrossRefPubMed

Fonseka P, Pathan M, Chitti SV, Kang T, Mathivanan S (2020) FunRich enables enrichment analysis of OMICs datasets. J Mol Biol. https://doi.org/10.1016/j.jmb.2020.166747CrossRefPubMed

Gao Z, Liu R, Liao J, Yang M, Pan E, Yin L, Pu Y (2016) Possible tumor suppressive role of the miR-144/451 cluster in esophageal carcinoma as determined by principal component regression analysis. Mol Med Rep 14:3805–3813. https://doi.org/10.3892/mmr.2016.5691CrossRefPubMed

Goodall GJ, Wickramasinghe VO (2021) RNA in cancer. Nat Rev Cancer 21:22–36. https://doi.org/10.1038/s41568-020-00306-0CrossRefPubMed

Gu YY et al (2018) Matrine induces apoptosis in multiple colorectal cancer cell lines in vitro and inhibits tumour growth with minimum side effects in vivo via Bcl-2 and caspase-3. Phytomedicine 51:214–225. https://doi.org/10.1016/j.phymed.2018.10.004CrossRefPubMed

Guo W et al (2015) MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer. Hepatology 62:1132–1144. https://doi.org/10.1002/hep.27929CrossRefPubMed

Han B et al (2018a) MicroRNA-144 mediates chronic inflammation and tumorigenesis in colorectal cancer progression via regulating C-X-C motif chemokine ligand 11. Exp Ther Med 16:1935–1943. https://doi.org/10.3892/etm.2018a.6389CrossRefPubMedPubMedCentral

Han B et al (2018b) NUDCD1 promotes metastasis through inducing EMT and inhibiting apoptosis in colorectal cancer. Am J Cancer Res 8:810–823PubMedPubMedCentral

He B, Xia S, Zhang Z (2020a) NudCD1 promotes the proliferation and metastasis of non-small cell lung cancer cells through the activation of IGF1R-ERK1/2. Pathobiology 87:244–253. https://doi.org/10.1159/000505159CrossRefPubMed

He L, Liao L, Du L (2020b) miR1443p inhibits tumor cell growth and invasion in oral squamous cell carcinoma through the downregulation of the oncogenic gene, EZH2. Int J Mol Med 46:828–838. https://doi.org/10.3892/ijmm.2020.4638CrossRefPubMedPubMedCentral

Hu Y et al (2018) Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer. Clin Epigenet 10:154. https://doi.org/10.1186/s13148-018-0592-yCrossRef

Huo F, Zhang C, He H, Wang Y (2016) MicroRNA-144-3p inhibits proliferation and induces apoptosis of human salivary adenoid carcinoma cells via targeting of mTOR. Biotechnol Lett 38:409–416. https://doi.org/10.1007/s10529-015-2007-xCrossRefPubMed

Iwaya T et al (2012) Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis 33:2391–2397. https://doi.org/10.1093/carcin/bgs288CrossRefPubMed

Ji X et al (2019) miR-144 suppresses cell proliferation and migration in colorectal cancer by targeting NRAS. J Cell Biochem. https://doi.org/10.1002/jcb.29543CrossRefPubMed

Jiang X et al (2015) miR-144/451 promote cell proliferation via targeting PTEN/AKT pathway in insulinomas. Endocrinology 156:2429–2439. https://doi.org/10.1210/en.2014-1966CrossRefPubMed

Jin J, Wang Y, Xu Y, Zhou X, Liu Y, Li X, Wang J (2017) MicroRNA-144 regulates cancer cell proliferation and cell-cycle transition in acute lymphoblastic leukemia through the interaction of FMN2. J Gene Med. https://doi.org/10.1002/jgm.2898CrossRefPubMed

Kim MJ et al (2020) Novel SIRT inhibitor, MHY2256, induces cell cycle arrest, apoptosis, and autophagic cell death in HCT116 human colorectal cancer cells. Biomol Ther (seoul) 28:561–568. https://doi.org/10.4062/biomolther.2020.153CrossRef

Kooshkaki O et al (2020) MiR-144: a new possible therapeutic target and diagnostic/prognostic tool in cancers. Int J Mol Sci. https://doi.org/10.3390/ijms21072578CrossRefPubMedPubMedCentral

Li J, Sun P, Yue Z, Zhang D, You K, Wang J (2017) miR-144–3p induces cell cycle arrest and apoptosis in pancreatic cancer cells by targeting proline-rich protein 11 expression via the mitogen-activated protein kinase signaling pathway. DNA Cell Biol 36:619–626. https://doi.org/10.1089/dna.2017.3656CrossRefPubMed

Liu F, Chen N, Xiao R, Wang W, Pan Z (2016) miR-144–3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8. Biochem Biophys Res Commun 480:87–93. https://doi.org/10.1016/j.bbrc.2016.10.004CrossRefPubMed

Liu JL et al (2019) MiR-144 inhibits tumor growth and metastasis in osteosarcoma via dual-suppressing RhoA/ROCK1 signaling pathway. Mol Pharmacol 95:451–461. https://doi.org/10.1124/mol.118.114207CrossRefPubMed

Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262CrossRefPubMed

Nagy A, Lanczky A, Menyhart O, Gyorffy B (2018) Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep 8:9227. https://doi.org/10.1038/s41598-018-27521-yCrossRefPubMedPubMedCentral

Ovcharenko D, Kelnar K, Johnson C, Leng N, Brown D (2007) Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res 67:10782–10788. https://doi.org/10.1158/0008-5472.CAN-07-1484CrossRefPubMed

Padmanaban V, Krol I, Suhail Y, Szczerba BM, Aceto N, Bader JS, Ewald AJ (2019) E-cadherin is required for metastasis in multiple models of breast cancer. Nature 573:439–444. https://doi.org/10.1038/s41586-019-1526-3CrossRefPubMedPubMedCentral

Rao W et al (2014a) OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells. Carcinogenesis 35:1573–1581. https://doi.org/10.1093/carcin/bgu070CrossRefPubMed

Rao W et al (2014b) OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells. PLoS ONE 9:e85705. https://doi.org/10.1371/journal.pone.0085705CrossRefPubMedPubMedCentral

Rasmussen KD et al (2010) The miR-144/451 locus is required for erythroid homeostasis. J Exp Med 207:1351–1358. https://doi.org/10.1084/jem.20100458CrossRefPubMedPubMedCentral

Roskoski R Jr (2012) ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res 66:105–143. https://doi.org/10.1016/j.phrs.2012.04.005CrossRefPubMed

Roskoski R Jr (2019) Targeting ERK1/2 protein-serine/threonine kinases in human cancers. Pharmacol Res 142:151–168. https://doi.org/10.1016/j.phrs.2019.01.039CrossRefPubMed

Shi C et al (2021) NUDCD1 knockdown inhibits the proliferation, migration, and invasion of pancreatic cancer via the EMT process. Aging (albany NY) 13:18298–18309. https://doi.org/10.18632/aging.203276CrossRef

Sheng S, Xie L, Wu Y, Ding M, Zhang T, Wang X (2019) MiR-144 inhibits growth and metastasis in colon cancer by down-regulating SMAD4. Biosci Rep. https://doi.org/10.1042/BSR20181895

Song F, Chen Q, Rao W, Zhang R, Wang Y, Ge H, Wei Q (2019) OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling. EBioMedicine 41:156–166. https://doi.org/10.1016/j.ebiom.2019.02.051CrossRefPubMedPubMedCentral

Sun J et al (2017) E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle. J Exp Clin Cancer Res 36:40. https://doi.org/10.1186/s13046-017-0504-6CrossRefPubMedPubMedCentral

Sun N, Zhang L, Zhang C, Yuan Y (2020) miR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt/beta-catenin signaling. Cell Mol Biol Lett 25:19. https://doi.org/10.1186/s11658-020-00210-3CrossRefPubMedPubMedCentral

Sureban SM et al (2011) Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism. J Nanobiotechnol 9:40. https://doi.org/10.1186/1477-3155-9-40CrossRef

Szklarczyk D, Jensen LJ (2015) Protein–protein interaction databases. Methods Mol Biol 1278:39–56. https://doi.org/10.1007/978-1-4939-2425-7_3CrossRefPubMed

Wang Q et al (2008) RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells. Cancer Lett 269:127–138. https://doi.org/10.1016/j.canlet.2008.04.035CrossRefPubMed

Wang X et al (2012) Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res 94:379–390. https://doi.org/10.1093/cvr/cvs096CrossRefPubMedPubMedCentral

Wong NW, Chen Y, Chen S, Wang X (2018) OncomiR: an online resource for exploring pan-cancer microRNA dysregulation. Bioinformatics 34:713–715. https://doi.org/10.1093/bioinformatics/btx627CrossRefPubMed

Zhao S, Xue H, Hao CL, Jiang HM, Zheng HC (2020) BTG1 overexpression might promote invasion and metastasis of colorectal cancer via decreasing adhesion and inducing epithelial-mesenchymal transition. Front Oncol 10:598192. https://doi.org/10.3389/fonc.2020.598192CrossRefPubMedPubMedCentral

Zhou S, Ye W, Zhang Y, Yu D, Shao Q, Liang J, Zhang M (2016) miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway. Am J Transl Res 8:2992–3002PubMedPubMedCentral

Zhou J et al (2019) Antitumor activity in colorectal cancer induced by hinokiflavone. J Gastroenterol Hepatol 34:1571–1580. https://doi.org/10.1111/jgh.14581CrossRefPubMed

Zhou M, Wu Y, Li H, Zha X (2020) MicroRNA-144: a novel biological marker and potential therapeutic target in human solid cancers. J Cancer 11:6716–6726. https://doi.org/10.7150/jca.46293CrossRefPubMedPubMedCentral

Titel: miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification
verfasst von: Bin Han
Ke Xu
Dan Feng
Yang Bai
Yangqi Liu
Yuanyuan Zhang
Liming Zhou
Publikationsdatum: 27.04.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 8/2022
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-022-03951-0

Springer Medizin

miR-144 inhibits the IGF1R-ERK1/2 signaling pathway via NUDCD1 to suppress the proliferation and metastasis of colorectal cancer cells: a study based on bioinformatics and in vitro and in vivo verification

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2022

Molecular diagnostics and therapies for gastrointestinal tumors: a real-world experience

Blimp-1 is a prognostic indicator for progression of cervical intraepithelial neoplasia grade 2

Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML)

Immunological and nutritional predictive factors in patients receiving pembrolizumab for the first-line treatment of non-small cell lung cancer

Diet and gastric cancer risk: an umbrella review of systematic reviews and meta-analyses of prospective cohort studies

Radiotherapy for glioblastoma patients with poor performance status

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie